These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34931285)
21. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Tanno F; Nishiyama Y; Kokubo H; Obara S Drug Dev Ind Pharm; 2004 Jan; 30(1):9-17. PubMed ID: 15000425 [TBL] [Abstract][Full Text] [Related]
22. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide. Zhang HJ; Chiang CW; Maschmeyer-Tombs T; Conklin B; Napolitano JG; Lubach JW; Nagapudi K; Mao C; Chen Y Mol Pharm; 2024 Jul; 21(7):3395-3406. PubMed ID: 38836777 [TBL] [Abstract][Full Text] [Related]
23. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media. Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638 [TBL] [Abstract][Full Text] [Related]
24. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder. Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911 [TBL] [Abstract][Full Text] [Related]
25. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets. Shibata H; Yoshida H; Izutsu K; Goda Y J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275 [TBL] [Abstract][Full Text] [Related]
26. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865 [TBL] [Abstract][Full Text] [Related]
27. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic. Butreddy A Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180 [TBL] [Abstract][Full Text] [Related]
28. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. Sun DD; Ju TC; Lee PI Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548 [TBL] [Abstract][Full Text] [Related]
29. Dissolution Profiles of Oral Disintegrating Tablet with Taste Masking Granule Polymer Coating in Biorelevant Bicarbonate Buffer. Higashino M; Sugano K Chem Pharm Bull (Tokyo); 2024; 72(3):298-302. PubMed ID: 38479857 [TBL] [Abstract][Full Text] [Related]
30. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Sheng JJ; McNamara DP; Amidon GL Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104 [TBL] [Abstract][Full Text] [Related]
31. Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole. Monschke M; Kayser K; Wagner KG AAPS PharmSciTech; 2021 Jan; 22(1):44. PubMed ID: 33438107 [TBL] [Abstract][Full Text] [Related]
32. Tailoring supersaturation from amorphous solid dispersions. Li N; Taylor LS J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798 [TBL] [Abstract][Full Text] [Related]
33. Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions. Chavan RB; Lodagekar A; Shastri NR Drug Dev Ind Pharm; 2018 Dec; 44(12):1933-1941. PubMed ID: 30102080 [TBL] [Abstract][Full Text] [Related]
34. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers. Merchant HA; Goyanes A; Parashar N; Basit AW Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730 [TBL] [Abstract][Full Text] [Related]
35. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release. Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834 [TBL] [Abstract][Full Text] [Related]
36. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions. Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151 [TBL] [Abstract][Full Text] [Related]
37. In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases. Krieg BJ; Taghavi SM; Amidon GL; Amidon GE J Pharm Sci; 2015 Sep; 104(9):2894-904. PubMed ID: 25980464 [TBL] [Abstract][Full Text] [Related]
38. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations. Xie T; Taylor LS Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205 [TBL] [Abstract][Full Text] [Related]
39. Correlation between drug dissolution and resistance to water-induced phase separation in solid dispersion formulations revealed by solid-state NMR spectroscopy. Okada H; Ueda K; Yasuda Y; Higashi K; Inoue M; Ito M; Noguchi S; Kawakami K; Moribe K Int J Pharm; 2020 Mar; 577():119086. PubMed ID: 31991185 [TBL] [Abstract][Full Text] [Related]
40. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type. Jackson MJ; Kestur US; Hussain MA; Taylor LS Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]